Wei G. Dong
Experienced in Truncus Arteriosus

Wei G. Dong

State Key Laboratory Of Robotics And System, 
Harbin, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Truncus Arteriosus
State Key Laboratory Of Robotics And System, 
Harbin, CN 
OverviewLocationsClinical Research

Overview

Wei Dong practices in Harbin, China. Dong is rated as an Experienced expert by MediFind in the treatment of Truncus Arteriosus. Their top areas of expertise are Liver Cancer, Supravalvular Aortic Stenosis, Cerebral Hypoxia, Osteotomy, and Hepatectomy.

Their clinical research consists of co-authoring 887 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Truncus Arteriosus.

Locations

State Key Laboratory Of Robotics And System, Harbin, China
Other Locations
No. 225 Changhai Road, Yangpu, 200438, China
Union Hospital, Wuhan, 430022, China
1678 Dongfang Road, Pudong, 200127, China
305 Zhongshan East Road, Nanjing, 210002, China
No. 89 Donggang Road, Shijiazhuang, 050031, China
No. 135 Yaguan Road, Xianshuigu, 300354, China
1678 Dongfang Road, Dongfang, China
Pr, Guangzhou, China
No. 17, Yongwai Zheng Street, Nanchang, 330006, China
Dongling Road 120, Shenyang, 110866, China
Jie Fang Road 238, Wuhan, 430060, China
Haping Road, Harbin, 150081, China
No. 119, South Fourth Ring West Road, Fengtai, 100070, China
103 Wenhua Road, Shenyang, 110016, China
107th Yanjiangxi Road, Guangzhou, China
Tat Chee Avenue, Hong Kong, China
1678 Dong Fang Road, Dongfang, 200127, China
#38, Zheda Road, Hangzhou, 310027, China
China Japan Union Hospital Of Jilin University, Changchun, 130031, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.
A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.
Enrollment Status: Recruiting
Publish Date: February 01, 2024
Intervention Type: Drug
Study Drug: rhNRG-1
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure on Standard Heart Failure Therapy
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure on Standard Heart Failure Therapy
Enrollment Status: Completed
Publish Date: July 25, 2024
Intervention Type: Drug
Study Drug: Recombinant Human Neuregulin for Injection
Study Phase: Phase 3
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
Enrollment Status: Terminated
Publish Date: December 21, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

887 Total Publications

Strain-Engineered PbS Quantum Dot Solar Cells with Suppressed Trap States and Enhanced Performance.
Strain-Engineered PbS Quantum Dot Solar Cells with Suppressed Trap States and Enhanced Performance.
Journal: Nano letters
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dong's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 125 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile